+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Estimation of radiation doses for atomic-bomb survivors in the Hiroshima University Registry



Estimation of radiation doses for atomic-bomb survivors in the Hiroshima University Registry



Health Physics 70(5): 735-740



The present study presents the Hiroshima University Registry of atomic bomb survivors, of which the total number is about 270,000, and application of absorbed doses. From this registry, we picked up 49,102 survivors and applied organ doses based on the dosimetry system 1986 (DS86), which is named the Atomic Bomb Survivor 1993 Dose (ABS93D). The applied dose data are based on the tables listed in the DS86 final report such as the free-in-air kermas, the house shielding factors, and organ dose factors for the active bone marrow and the breast. Calculations for the 13 other organs provided in DS86 are possible. To obtain the organ doses for each survivor, it is necessary to obtain information concerning (1) place exposed, (2) whether they were shielded or not, and (3) age. ABS93D body transmission factors for active bone marrow for neutrons and gamma rays agreed with DS86 to within a few percent. Of the survivors studied, 35,123 of them were used for the relative risk estimation of leukemia mortality, adopting the same method as the Radiation Effects Research Foundation (RERF) for comparison. For the observation period from 1968 to 1989, the analyzed relative risks for leukemia mortality at 1 Gy by shielded kerma and by active bone marrow dose are 2.01 and 2.37, respectively, which are consistent with the RERF results.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 008626195

Download citation: RISBibTeXText

PMID: 8690587

DOI: 10.1097/00004032-199605000-00017


Related references

Leukemia and radiation doses in atomic bomb survivors of hiroshima and nagasaki. Acta Haematologica Japonica 36(3): 304, 1973

Estimation of radiation doses for Nagasaki atomic bomb survivors based on the ABS93D (Atomic Bomb Survivor 1993 Dose). Nagasaki Igakkai Zasshi 72(1): 30-46, 1997

Supplement: Cancer Incidence in Atomic Bomb Survivors. Radiation Effects Research Foundation, Hiroshima and Nagasaki, Japan || Cancer Incidence in Atomic Bomb Survivors. Part I: Use of the Tumor Registries in Hiroshima and Nagasaki for Incidence Studies. Radiation Research 137(2): S1-S16, 1994

Parathyroid tumors in atomic bomb survivors in Hiroshima: epidemiological study from registered cases at Hiroshima Prefecture Tumor Tissue Registry, 1974-1987. Japanese Journal of Cancer Research 82(8): 875-878, 1991

Supplement: Cancer Incidence in Atomic Bomb Survivors. Radiation Effects Research Foundation, Hiroshima and Nagasaki, Japan || Cancer Incidence in Atomic Bomb Survivors. Part II: Solid Tumors, 1958-1987. Radiation Research 137(2): S17-S67, 1994

Supplement: Cancer Incidence in Atomic Bomb Survivors. Radiation Effects Research Foundation, Hiroshima and Nagasaki, Japan || Cancer Incidence in Atomic Bomb Survivors. Part III: Leukemia, Lymphoma and Multiple Myeloma, 1950-1987. Radiation Research 137(2): S68-S97, 1994

Supplement: Cancer Incidence in Atomic Bomb Survivors. Radiation Effects Research Foundation, Hiroshima and Nagasaki, Japan || Cancer Incidence in Atomic Bomb Survivors. Part IV: Comparison of Cancer Incidence and Mortality. Radiation Research 137(2): S98-S112, 1994

Noncancer mortality based on the Hiroshima atomic bomb survivors registry over 30 years, 1968-1997. Medical Journal of Hiroshima University 50(2): 73-83, 2002

Analysis of cancer mortality among atomic bomb survivors registered at Hiroshima University. International Journal of Radiation Biology 71(5): 603-611, 1997

Radiation dosimetry in Hiroshima and Nagasaki atomic-bomb survivors. New England Journal of Medicine 263: 488-493, 1960

Radiation therapy among atomic bomb survivors, Hiroshima and Nagasaki. Radiation Research 149(6): 614-624, 1998

Nonparametric Estimation of the Hazard Function by Using a Model Selection Method: Estimation of Cancer Deaths in Hiroshima Atomic Bomb Survivors. Journal of the Royal Statistical Society: Series C 54(2): 317-331, 2005

Nonparametric estimation of the hazard function by using a model selection method: estimation of cancer deaths in Hiroshima atomic bomb survivors. Journal of the Royal Statistical Society: Series C 54(2): 317-331, 2005

Hematological observation of atomic bomb survivors living in Tokyo about ten years after atomic bomb explosions in Hiroshima and Nagasaki. Keio Jour Med 6(3): 99-112, 1957

Radiation exposure and thyroid disease in Hiroshima and Nagasaki atomic bomb survivors. JAMA 296(5): 512; Author Reply 512-3, 2006